Possibly, the most serious flaw in the Medicare system is the fact that
a. the deductible is too high for most older Americans to afford.
b. it provides no real protection against catastrophic losses resulting from unusually
long hospital stays.
c. the definition of an episode of illness can lead to patients paying the deductible
more than once during the calendar year.
d. coverage for outpatient drugs is poor.
e. elders are required to pay monthly premiums to participate in Part B.
Give this one a try later!
b. it provides no real protection against catastrophic losses resulting
from unusually long hospital stays.
Government regulators sometimes set the price of a drug at its marginal cost of
production without including a fair share of the global joint cost of research and
development. Which of the following statements is true about this practice?
,a.
It assures consumers of the unlimited availability of the drug.
b.
This practice is a classic example of free riding.
c.
Setting drug prices at the marginal cost of production expands the market and
guarantees that total drug spending covers all costs, including fixed development
costs.
d.
The described practice is almost impossible because development costs are easily
divided among consumers and prices to reflect differences in the relative benefits
each receives.
e.
This behavior is highly unlikely because every country pays its fair share of the cost of
research and development.
Give this one a try later!
b.
This practice is a classic example of free riding.
The only disease-specific group eligible for Medicare are those suffering from:
a.
advanced coronary artery disease.
b.
metastasized cancer.
c.
end-stage renal disease.
d.
acquired immunodeficiency syndromes (AIDS).
e.
diabetes.
Give this one a try later!
, c.
end-stage renal disease.
Which benefits are provided through Part A of Medicare?
a.
Outpatient prescription drug insurance
b.
Medical hospital insurance
c.
Medicare Advantage (MA)
d.
Supplemental medical insurance
Give this one a try later!
b.
Medical hospital insurance
How much did pharmaceutical companies spend on direct-to-consumer advertising
in 2019?
a.
$27 billion
b.
$4.3 billion
c.
$9.8 billion
d.
$791 million
e.
$6.1 billion
Give this one a try later!
, e.
$6.1 billion
The dominant factor affecting medical care delivery and finance in the 1980s was
a. the Hill-Burton Act.
b. prospective payment for hospitals.
c. The creation of Medicare and Medicaid.
d. the explosive growth of managed care.
e. ERISA.
Give this one a try later!
b. prospective payment for hospitals
In 2010, the medical specialty that earned the highest rate of return on investment was
a. general primary care.
b. Internal medicine.
c. Pediatrics.
d. orthopedic surgery.
e. none of the above.
Give this one a try later!
d. orthopedic surgery.
By the time a drug enters the clinical trial phase of testing on humans,
a.
it has already completed most of the investment in research and development.
b.
its approval is virtually assured.
a. the deductible is too high for most older Americans to afford.
b. it provides no real protection against catastrophic losses resulting from unusually
long hospital stays.
c. the definition of an episode of illness can lead to patients paying the deductible
more than once during the calendar year.
d. coverage for outpatient drugs is poor.
e. elders are required to pay monthly premiums to participate in Part B.
Give this one a try later!
b. it provides no real protection against catastrophic losses resulting
from unusually long hospital stays.
Government regulators sometimes set the price of a drug at its marginal cost of
production without including a fair share of the global joint cost of research and
development. Which of the following statements is true about this practice?
,a.
It assures consumers of the unlimited availability of the drug.
b.
This practice is a classic example of free riding.
c.
Setting drug prices at the marginal cost of production expands the market and
guarantees that total drug spending covers all costs, including fixed development
costs.
d.
The described practice is almost impossible because development costs are easily
divided among consumers and prices to reflect differences in the relative benefits
each receives.
e.
This behavior is highly unlikely because every country pays its fair share of the cost of
research and development.
Give this one a try later!
b.
This practice is a classic example of free riding.
The only disease-specific group eligible for Medicare are those suffering from:
a.
advanced coronary artery disease.
b.
metastasized cancer.
c.
end-stage renal disease.
d.
acquired immunodeficiency syndromes (AIDS).
e.
diabetes.
Give this one a try later!
, c.
end-stage renal disease.
Which benefits are provided through Part A of Medicare?
a.
Outpatient prescription drug insurance
b.
Medical hospital insurance
c.
Medicare Advantage (MA)
d.
Supplemental medical insurance
Give this one a try later!
b.
Medical hospital insurance
How much did pharmaceutical companies spend on direct-to-consumer advertising
in 2019?
a.
$27 billion
b.
$4.3 billion
c.
$9.8 billion
d.
$791 million
e.
$6.1 billion
Give this one a try later!
, e.
$6.1 billion
The dominant factor affecting medical care delivery and finance in the 1980s was
a. the Hill-Burton Act.
b. prospective payment for hospitals.
c. The creation of Medicare and Medicaid.
d. the explosive growth of managed care.
e. ERISA.
Give this one a try later!
b. prospective payment for hospitals
In 2010, the medical specialty that earned the highest rate of return on investment was
a. general primary care.
b. Internal medicine.
c. Pediatrics.
d. orthopedic surgery.
e. none of the above.
Give this one a try later!
d. orthopedic surgery.
By the time a drug enters the clinical trial phase of testing on humans,
a.
it has already completed most of the investment in research and development.
b.
its approval is virtually assured.
